✦ LIBER ✦

MMPs: a novel drug target for schizophrenia

✍ Scribed by Chopra, Kanwaljit; Baveja, Ankita; Kuhad, Anurag

Book ID: 126517164
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 659 KB
Volume: 19
Category: Article
ISSN: 1472-8222
DOI: 10.1517/14728222.2014.957672

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE MGLU2 RECEPTOR AS A NOVEL DRUG TARGE

THE MGLU2 RECEPTOR AS A NOVEL DRUG TARGET FOR SCHIZOPHRENIA

✍ Kjell Svensson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Novel targets for novel antidepressant d

Novel targets for novel antidepressant drugs

✍ M. Isaac 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Dopaminergic dysregulation in schizophre

Dopaminergic dysregulation in schizophrenia: A target for new drugs

✍ Dr. Kenneth L. Davis; Michael Fiori; Bonnie M. Davis; Richard C. Mohs; Thomas B. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 816 KB

The dopamine hypothesis postulates that at least some schizophrenic symptoms are a reflection of central nervous system hyperdopaminergia. The evidence for this model is briefly reviewed and its shortcomings highlighted. The dysregulation hypothesis of schizophrenia should be a useful reformulation.

Novel targets for drug discovery

✍ Robert W. Wallace 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Targeting information-processing deficit

Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery

✍ Mihály Hajós 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 304 KB

PDE10A Inhibitors: Novel Therapeutic Dru

PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

✍ Kehler, Jan; Nielsen, Jacob 📂 Article 📅 2011 🏛 Bentham Science Publishers 🌐 English ⚖ 409 KB